Читать «Будущее медицины: Ваше здоровье в ваших руках» онлайн - страница 232

Эрик Тополь

60. A. Krol, "Show, Don't Tell: 23andMe Pursues Health Research in the Shadow of the FDA,"Bio-IT World, March 24, 2014, http://www.bio-it world.com/2014/3/24/show-dont-tell-23andme-pursues-health-research-shadow-fda.html.

61. D. Kroll, "Why The FDA Can't Be Flexible With 23andMe," Forbes, November 28, 2013, http://www.forbes.com/sites/davidkroll/2013/11/28/why-the-fda-cant-be-flexible-with-23andme-by-law/.

62. P. Loftus, "23andMe Stops Genetic Test Marketing," Wall Street Journal, December 2, 2013, http://online.wsj.com/news/articles/ SB10001424052702304579404579234503409624522.

63. P. Loftus, "Genetic Test Service 23andMe Ordered to Halt Marketing by FDA," Wall Street Journal, November 25, 2013: http://online.wsj.com/news/articles/ SB10001424052702304281004579219893863966448.

64. P. Loftus and R. Winslow, "23andMe CEO Responds to FDA Warning Letter," Wall Street Journal, November 27, 2013, http://online.wsj.com/news/articles/ SB10001424052702303332904579224093983156448.

65. G. Lyon, "Stopping 23andMe Will Only Delay the Revolution Medicine Needs," The Conversation, November 25, 2013, http://theconversation.com/stopping-23andme-will-only-delay-the-revolution-medicine-needs-20743.

66. V. Hughes, "23 a nd You," Medium, December 4, 2013, https://medium.com/matter/66e87553d22c.

67. "The FDA vs. 23andMe: A Lesson for Health Care Entrepreneurs," Knowledge at Wharton(K@W), December 18, 2013, http://knowledge.wharton.upenn.edu/article/fda-vs-23andme-lesson-health-care-entrepreneurs/.

68. R. Bailey, "Leave 23andMe Alone," Reason.com, February 25, 2014, http://reason.com/archives/2014/02/25/leave-23andme-alone/print.

69. H. Binswanger, "FDA Says, 'No Gene Test for You: You Can't Handle the Truth,'" Forbes, November 26, 2013, http://www.forbes.com/sites/harrybinswanger/2013/11/26/fda-says-no-gene-test-for-you-you-cant-handle-the-truth/.

70. M. Allison, "Direct-to-Consumer Genomics Reinvents Itself," Nature Biotechnology 30, no. 11 (2012): 1027–1029.

71. G. J. Annas and S. Elias, "23andMe and the FDA," New England Journal of Medicine 370 (2014): 985–988.

72. M. White, "The FDA is Not Anti-Genetics," Pacific Standard, January 17, 2014: http://www.psmag.com/navigation/nature-and-technology/fda-anti-genetics-72987/.

73. C. Wood, "Does the FDA Think You're Stupid?" Casey Research, December 5, 2013, http://www.caseyresearch.com/cdd/does-the-fda-think-youre-stupid.

74. C. Farr, "23andMe Remains Optimistic Despite FDA Issues: 'We Are Not Going Anywhere' (Exclusive)," Venture Beat, December 7, 2013, http://venturebeat.com/2013/12/07/23andme-remains-defiant-despite-fda-issues-we-are-not-going-anywhere-exclusive/2/.

75. L. Downes and P. Nunes, "Regulating 23andMe to Death Won't Stop the New Age of Genetic Testing," Wired, January 1, 2014, http://www.wired.com/opinion/2014/01/the-fda-may-win-the-battle-this-holiday-season-but-23andme-will-win-the-war/.

76. N. S. Downing and J. S. Ross, "Innovation, Risk, and Patient Empowerment The FDA-Mandated Withdrawal of 23andMe's Personal Genome Service," Journal of the American Medical Association 311, no. 8 (2014): 793–794.